Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable heart monitor works during scans, study finds

NCT ID NCT07714109

Knowledge-focused Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether a 12-lead wearable Holter monitor can be worn during MRI, CT, X-ray, and echocardiography without affecting image quality or the device's ability to record heart signals. Researchers will enroll 500 adults who need these imaging exams and will check for equipment failures, signal interference, or side effects. The goal is to see if combining heart monitoring with routine scans can shorten hospital visits and catch more heart rhythm problems.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that wearable heart monitors can be used safely during common imaging tests, making heart monitoring more convenient and improving arrhythmia detection.
What could go wrong
This is an early compatibility study, not a treatment trial. It may not prove clinical benefit, and results might not apply to all patients or devices.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients aged 18 to 99 years old who need to receive MRI, CT, X-ray or echocardiography examinations, and are willing to wear 12-lead wearable ambulatory electrocardiography and sign informed consent.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Aged ≥18 years old; 2. Patients requiring MRI, CT, X-ray or cardiac ultrasound examination; 3. Voluntarily wear the 12-lead wearable ambulatory electrocardiography device during imaging examination; 4. Able to understand and sign the informed consent form independently. Exclusion Criteria: 1. Severe skin damage, infection or allergy on chest skin unable to attach ECG electrodes; 2. Unstable critical condition, emergency rescue state; 3. Permanent magnet-containing implantable devices incompatible with magnetic resonance; 4. Mental disorders or cognitive dysfunction unable to cooperate with examination; 5. Pregnant women.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac arrhythmia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac arrhythmia

Contacts and locations

Locations

  • The Second Affiliated Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310009, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.